GI
MJN

Gradient Investments’s Mead Johnson Nutrition Company MJN Stock Holding History

Gradient Investments’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1
Closed – – 778
2015
Q3 		$0 Buy
+1
New +$82 ﹤0.01% 729

Other funds holding MJN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gradient Investments's MJN Position: Q4 2015 in Review

Gradient Investments sold out of Mead Johnson Nutrition Company (MJN) in Q4 2015, closing a stake of 1 share.

Gradient Investments first reported a position in MJN in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 549 funds tracked by Wall St. Rank hold MJN as of Q4 2015.

  • Gradient Investments reported no remaining Mead Johnson Nutrition Company position as of Q4 2015 after selling out during the quarter.
  • Gradient Investments sold 1 Mead Johnson Nutrition Company share in Q4 2015.
  • Gradient Investments first reported a position in Mead Johnson Nutrition Company in Q3 2015 and held it in 1 quarter.
  • Gradient Investments's Mead Johnson Nutrition Company position peaked at $0 in Q3 2015.
  • 549 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2015.

Based on Gradient Investments's 13F filing for Q4 2015, filed 19 Jan 2016.